NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $21,372,435 | +118.6% | 211,797 | +99.3% | 0.18% | +95.7% |
Q1 2023 | $9,777,484 | +102.0% | 106,277 | +66.9% | 0.09% | +129.3% |
Q3 2022 | $4,841,000 | -61.9% | 63,688 | -56.1% | 0.04% | -64.3% |
Q1 2022 | $12,716,000 | +1532.3% | 144,915 | +1528.3% | 0.12% | +1542.9% |
Q4 2021 | $779,000 | -63.9% | 8,900 | -66.3% | 0.01% | -68.2% |
Q3 2021 | $2,159,000 | +647.1% | 26,400 | +695.2% | 0.02% | +266.7% |
Q3 2020 | $289,000 | -94.7% | 3,320 | -94.3% | 0.01% | -95.5% |
Q4 2019 | $5,502,000 | +60.3% | 58,107 | +62.7% | 0.13% | +12.6% |
Q1 2019 | $3,433,000 | +144.3% | 35,706 | +92.0% | 0.12% | +56.6% |
Q2 2018 | $1,405,000 | -45.7% | 18,600 | -41.9% | 0.08% | -60.8% |
Q1 2018 | $2,588,000 | +795.5% | 32,014 | +851.9% | 0.19% | +646.2% |
Q3 2017 | $289,000 | -37.2% | 3,363 | -39.0% | 0.03% | -44.7% |
Q2 2017 | $460,000 | -72.8% | 5,516 | -74.2% | 0.05% | -83.6% |
Q3 2016 | $1,691,000 | +383.1% | 21,405 | +342.9% | 0.29% | +100.7% |
Q1 2016 | $350,000 | – | 4,833 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |